With questions or comments, please reach out to us: 

In this episode, we discuss medications that can reduce the risk of developing breast cancer in women at increased risk. We review who should be offered risk-reducing endocrine therapy, compare tamoxifen, raloxifene, and aromatase inhibitors, and discuss how to individualize treatment based on menopausal status, medical history, and individual preferences. 

Twitter/X: @VkazakovaMD

Email: [email protected]

Music: 

Music by ⁠⁠⁠⁠Kyrylo Momot⁠⁠⁠⁠ (MomotMusic) from ⁠⁠⁠⁠Pixabay⁠⁠⁠⁠

The views expressed are those of the hosts and do not necessarily reflect those of their affiliated institutions. This podcast is for educational purposes only and is not medical advice.

In this episode, we continue answering common questions about genetic testing for cancer predisposition. We discuss insurance coverage, direct-to-consumer tests, when older genetic testing may need to be updated, and how to follow up on a variant of uncertain significance. We also explore what future parents should know about unexpected cancer predisposition findings during prenatal testing.

With questions or comments, please reach out to us: 

Twitter/X: @VkazakovaMD

Email: [email protected]

Music: 

Music by ⁠⁠⁠Kyrylo Momot⁠⁠⁠ (MomotMusic) from ⁠⁠⁠Pixabay⁠⁠⁠

The views expressed are those of the hosts and do not necessarily reflect those of their affiliated institutions. This podcast is for educational purposes only and is not medical advice.

In this episode, we answer common questions about genetic testing for cancer predisposition, including the difference between tumor and germline testing, what genes are included on hereditary cancer panels, what results may mean, how testing is done, and why results can matter for patients and their family members.

With questions or comments, please reach out to us: 

Twitter/X: @VkazakovaMD

Email: [email protected]

Music: 

Music by ⁠⁠Kyrylo Momot⁠⁠ (MomotMusic) from ⁠⁠Pixabay⁠⁠

The views expressed are those of the hosts and do not necessarily reflect those of their affiliated institutions. This podcast is for educational purposes only and is not medical advice.

In this episode, we take listeners inside a genetic counseling visit and walk through what clinicians and patients can expect before, during, and after genetic testing for cancer predisposition.

With questions or comments, please reach out to us: 

Twitter/X: @VkazakovaMD

Email: [email protected]

Music: 

Music by ⁠Kyrylo Momot⁠ (MomotMusic) from ⁠Pixabay⁠

The views expressed are those of the hosts and do not necessarily reflect those of their affiliated institutions. This podcast is for educational purposes only and is not medical advice.

In this episode, we break down the most commonly used breast cancer risk models—Gail, Tyrer–Cuzick (IBIS), BCSC, and CanRisk—and explore their pros, limitations, and how they fit into clinical workflows.

With questions or comments, please reach out to us: 

Twitter/X: @VkazakovaMD

Email: [email protected]

Music: 

Music by Kyrylo Momot (MomotMusic) from Pixabay

The views expressed are those of the hosts and do not necessarily reflect those of their affiliated institutions. This podcast is for educational purposes only and is not medical advice.

In this episode, we cover the fundamentals of breast cancer risk assessment—who to assess, when to start, what defines high risk, and how it can meaningfully change screening, genetic testing, and prevention strategies.

With questions or comments, please reach out to us:

Twitter/X: @VkazakovaMD

Email: [email protected]

Music:

Music by Kyrylo Momot (MomotMusic) from Pixabay

The views expressed are those of the hosts and do not necessarily reflect those of their affiliated institutions. This podcast is for educational purposes only and is not medical advice.